Steris (NYSE:STE) beat The Street on both sales and profits in its fiscal third quarter and announced that CEO Walt Rosebrough will step down July 29, 2021.
The Dublin, Ireland-based sterilization and surgical products company posted profits of $114.5 million or $1.33 per share, on sales of $808.9 million for the three months ended Dec. 31, 2020, for a 9% bottom-line gain on a sales boost of 4.5%.
Adjusted to exclude one-time items, earnings per share were $1.73, 19¢ ahead of Wall Street, where analysts were looking for sales of $793 million.
Get the full story on our sister site, Medical Design & Outsourcing.